Biotech Hangout cover image

Episode 63

Biotech Hangout

00:00

The Importance of Precision Medicine in Oncology

Cura oncology had a 35 percent CR rate in NPM1 mutin AML. Editha's promoting some very high data like they had for patients in sickle cell disease. Vertex has an update with their sickle cell program that looked really strong. They announced their feedie debates both for sicklecell disease and beta thalassemia.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app